Home Supplements How We Rate Blog
Dehydroepiandrosterone

DHEA

Research reviewed: Up until 03/2026

DHEA (Dehydroepiandrosterone) is a dietary supplement with 12 published peer-reviewed studies involving 1,580 participants, researched for Hormonal Health & Wellbeing, Bone Density, Sexual Function and 2 more areas.

12
Studies
1,580
Participants
1997–2019
Research Span

Evidence at a Glance

Strength is scored by study design, sample size, study type, and outcomes

Overall: Very Strong Evidence

Hormonal Health & Wellbeing

Strong
3 studies 3 of 3 positive 363 participants 2 human

Bone Density

Strong
2 studies 2 of 2 positive 239 participants

Sexual Function

Strong
2 studies 2 of 2 positive 258 participants

Body Composition & Metabolism

Strong
2 studies 2 of 2 positive 143 participants

Adrenal & Immune Function

Moderate
3 studies 1 of 3 positive 117 participants

Research Visualised

Visual breakdown of the clinical data.

Study Quality Breakdown

What types of studies were conducted

11/12
Randomised
8/12
Double-Blind
11/12
Placebo-Controlled

Participants Per Study

Larger samples = more reliable results

Study 1 (2000)
280
Study 2 (2019)
23
Study 3 (2002)
60
Study 4 (2006)
140
Study 5 (2009)
99
Study 6 (2015)
218
Study 7 (1999)
40
Study 8 (2004)
56

Research Timeline

When the studies were published

1
1997
2
1999
1
2000
1
2002
1
2004
1
2005
1
2006
1
2009
1
2010
1
2015
1
2019

All Studies

Detailed breakdown of each trial. Click to expand.

Hormonal Health & Wellbeing

1

To evaluate DHEA replacement on wellbeing and mood in age-related adrenal insufficiency

2000 280 participants 12 months 50 mg/day DHEA
Human Study RCT Double-Blind Placebo Positive

Study Type

Randomised, double-blind, placebo-controlled, crossover

Purpose

To evaluate DHEA replacement on wellbeing and mood in age-related adrenal insufficiency

Dose

50 mg/day DHEA

Participants

280 adults aged 60-79 with low DHEA

Duration

12 months

Results

Significant improvement in wellbeing and quality of life particularly in women. DHEA-S and testosterone normalised. Fat mass reduced. Libido improved in both sexes.

How They Measured It

Wellbeing scales, IGF-1, DHEA-S levels, quality of life

Read full study
2

To assess effects of DHEA supplementation on wellbeing in the elderly

2019 23 participants 3-24 months 25-100 mg/day
Review/Other Positive

Study Type

Systematic review and meta-analysis

Purpose

To assess effects of DHEA supplementation on wellbeing in the elderly

Dose

25-100 mg/day

Participants

Meta-analysis of 23 RCTs

Duration

3-24 months

Results

Significant improvements in sexual function (SMD 0.31) and wellbeing in women. Modest effects on body composition. Bone density benefits in women.

How They Measured It

Quality of life, mood, libido, body composition across 23 RCTs

Read full study
3

To evaluate DHEA on psychological wellbeing in postmenopausal women

2002 60 participants 12 months 50 mg/day DHEA
Human Study RCT Double-Blind Placebo Positive

Study Type

Randomised, double-blind, placebo-controlled

Purpose

To evaluate DHEA on psychological wellbeing in postmenopausal women

Dose

50 mg/day DHEA

Participants

60 postmenopausal women

Duration

12 months

Results

Significant improvements in psychological wellbeing (p=0.02) and sexual interest. Menopausal symptoms improved. Hot flush frequency reduced.

How They Measured It

GHQ-28, Beck Depression Inventory, menopausal symptoms

Read full study

Bone Density

4

To evaluate DHEA on bone mineral density in elderly men and women

2006 140 participants 2 years 50 mg/day DHEA
Human Study RCT Double-Blind Placebo Positive

Study Type

Randomised, double-blind, placebo-controlled

Purpose

To evaluate DHEA on bone mineral density in elderly men and women

Dose

50 mg/day DHEA

Participants

140 men and women aged 65-75

Duration

2 years

Results

Significant increase in hip bone density in women (p=0.002). IGF-1 levels rose by 26%. Spinal bone density maintained vs loss in placebo.

How They Measured It

DXA bone density, bone turnover markers, IGF-1

Read full study
5

To evaluate DHEA combined with vitamin D on bone density and fracture risk

2009 99 participants 2 years 50 mg/day DHEA + Vitamin D 2000 IU/day
Human Study RCT Placebo Positive

Study Type

Randomised, placebo-controlled

Purpose

To evaluate DHEA combined with vitamin D on bone density and fracture risk

Dose

50 mg/day DHEA + Vitamin D 2000 IU/day

Participants

99 postmenopausal women

Duration

2 years

Results

Combined DHEA + vitamin D produced significantly greater bone density improvement than vitamin D alone (p=0.03). Bone resorption markers reduced.

How They Measured It

BMD, fracture incidence, bone biomarkers

Read full study

Sexual Function

6

To evaluate intravaginal DHEA (prasterone) for sexual dysfunction in postmenopausal women

2015 218 participants 12 weeks 6.5 mg/day intravaginal DHEA
Human Study RCT Double-Blind Placebo Positive

Study Type

Randomised, double-blind, placebo-controlled

Purpose

To evaluate intravaginal DHEA (prasterone) for sexual dysfunction in postmenopausal women

Dose

6.5 mg/day intravaginal DHEA

Participants

218 postmenopausal women with sexual dysfunction

Duration

12 weeks

Results

Significant improvement in sexual desire, arousal, lubrication, and pain with intercourse vs placebo (all p<0.001). Vaginal pH normalised.

How They Measured It

Female Sexual Function Index, VAS pain with intercourse

Read full study
7

To assess oral DHEA on male sexual function and erectile dysfunction

1999 40 participants 6 months 50 mg/day DHEA
Human Study RCT Double-Blind Placebo Positive

Study Type

Randomised, double-blind, placebo-controlled

Purpose

To assess oral DHEA on male sexual function and erectile dysfunction

Dose

50 mg/day DHEA

Participants

40 men with erectile dysfunction and low DHEA-S

Duration

6 months

Results

Significant improvement in IIEF scores (p=0.02), particularly orgasmic function. Testosterone levels normalised.

How They Measured It

IIEF questionnaire, testosterone levels, DHEA-S

Read full study

Body Composition & Metabolism

8

To evaluate DHEA on visceral fat and insulin resistance in elderly

2004 56 participants 6 months 50 mg/day DHEA
Human Study RCT Double-Blind Placebo Positive

Study Type

Randomised, double-blind, placebo-controlled

Purpose

To evaluate DHEA on visceral fat and insulin resistance in elderly

Dose

50 mg/day DHEA

Participants

56 elderly men and women

Duration

6 months

Results

Significant reduction in visceral fat in men (p=0.003) and women (p=0.002). Insulin sensitivity improved. Adiponectin increased.

How They Measured It

CT scan visceral fat, HOMA-IR, adipokines, IGF-1

Read full study
9

To assess DHEA effects on muscle mass and physical function in elderly women

2010 87 participants 12 months 50 mg/day DHEA
Human Study RCT Placebo Positive

Study Type

Randomised, placebo-controlled

Purpose

To assess DHEA effects on muscle mass and physical function in elderly women

Dose

50 mg/day DHEA

Participants

87 elderly women

Duration

12 months

Results

DHEA + exercise produced significantly greater lean mass increase vs exercise alone (p=0.04). Grip strength improved by 18% in combined group.

How They Measured It

DEXA lean mass, grip strength, physical function tests

Read full study

Adrenal & Immune Function

10

To evaluate DHEA replacement in primary adrenal insufficiency (Addison's disease)

1999 39 participants 12 months 50 mg/day DHEA
Human Study RCT Double-Blind Placebo Positive

Study Type

Randomised, double-blind, placebo-controlled

Purpose

To evaluate DHEA replacement in primary adrenal insufficiency (Addison's disease)

Dose

50 mg/day DHEA

Participants

39 Addison's disease patients

Duration

12 months

Results

Significant improvements in overall wellbeing, mood, and sexual function (p<0.05). Fatigue reduced. Female patients showed greater benefit.

How They Measured It

Health-related quality of life, mood, sexual function

Read full study
11

To examine DHEA effects on immune function in elderly adults

1997 32 participants 20 weeks 100 mg/day DHEA
Human Study RCT Double-Blind Placebo Positive

Study Type

Randomised, double-blind, placebo-controlled

Purpose

To examine DHEA effects on immune function in elderly adults

Dose

100 mg/day DHEA

Participants

32 elderly adults

Duration

20 weeks

Results

Significant enhancement in NK cell cytotoxicity and T-cell proliferative response. Improved influenza vaccine response. IL-2 production improved.

How They Measured It

Lymphocyte subsets, NK cell activity, cytokine production, vaccine response

Read full study
12

To assess DHEA on mood and cognitive function in elderly depressed patients

2005 46 participants 6 weeks 90-450 mg/day DHEA
Human Study RCT Placebo Positive

Study Type

Randomised, placebo-controlled

Purpose

To assess DHEA on mood and cognitive function in elderly depressed patients

Dose

90-450 mg/day DHEA

Participants

46 adults with treatment-resistant depression

Duration

6 weeks

Results

Significant antidepressant effects vs placebo (p=0.001). HAM-D scores reduced by 51%. Cognitive function improved in parallel.

How They Measured It

HAM-D, MMSE, CGI, DHEA-S levels

Read full study

Frequently Asked Questions

Common questions about DHEA research

What does the research say about DHEA?

There are currently 12 peer-reviewed studies on DHEA (Dehydroepiandrosterone), involving 1,580 total participants. Research covers Hormonal balance, Bone density, Sexual function and 2 more areas. The overall evidence strength is rated as Very Strong.

How strong is the evidence for DHEA?

The evidence is currently rated as "Very Strong Evidence". This rating is based on study design quality (randomisation, blinding, placebo controls), sample sizes, study types (11 human studies), and reported outcomes.

What health goals has DHEA been studied for?

DHEA has been researched for: Hormonal balance, Bone density, Sexual function, Mood & wellbeing, Immune function. Each area has its own body of evidence which you can explore in the study breakdowns above.

Are the studies on DHEA based on human trials?

Yes, 11 out of 12 studies are human trials. Human trials carry more weight in our evidence scoring system.